Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
Part of paid clinical trials in Providence, Rhode Island.
- Sponsor
- Women and Infants Hospital of Rhode Island
- Study ID
- NCT06135636
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Non-birthing Partner Vaccination in Pregnancy
- Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination
- Vaccine Exposure During Pregnancy
Eligibility Criteria
- Sex
- ALL
- Age
- 19 Years - 50 Years
- Healthy Volunteers
- Accepted
Interventions
- Education — BEHAVIORALDirect verbal and written education at the time of enrollment on cocooning and recommendation for partner Tdap vaccination prior to delivery
- Vaccine administration — BIOLOGICALOption to receive Tdap at their convenience at the WIH obstetric care clinic provided to participant
Study Details
The goal of this randomized control trial is to assess if prenatal vaccine education and in-office vaccination administration for non-birthing partners of pregnant patients increases Tdap vaccination rates compared to usual care. The main question\[s\] it aims to answer are: * To assess whether compared to standard prenatal care, targeted prenatal education regarding Tdap vaccination recommendations with and without in office vaccination opportunities improves Tdap uptake among non-birthing partners of pregnant patients. * To assess whether non-birthing partners presenting for Tdap vaccination are willing to accept dual vaccination with Tdap and influenza. Participants will receive direct verbal and written education at the time of enrollment on cocooning and recommendation for partner Tdap vaccination prior to delivery with or without the option to receive Tdap at their convenience at the WIH obstetric care clinic. If there is a comparison group: Researchers will compare "Upfront Education" and "Upfront Education and Vaccination Administration" to "Usual care" to see if education and/or the offer for vaccination in the office increases Tdap vaccine acceptance for non-birthing partners.
Key Dates
- Start date
- May 28, 2024
- Status verified
- Sep 2024
- Primary completion
- Jun 30, 2025
- Completion
- Jun 30, 2025
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- No Intervention: Usual CareNo up-front education, routine counseling as per their primary provider's standard practice, and written education on cocooning and recommendation for partner Tdap vaccination provided upon completion of the postpartum survey
- Experimental: Upfront Education OnlyDirect verbal and written education at the time of enrollment on cocooning and recommendation for partner Tdap vaccination prior to delivery
- Experimental: Upfront Education and Vaccination Administration:Direct verbal and written education at the time of enrollment on cocooning and recommendation for partner Tdap vaccination prior to delivery plus the option to receive Tdap at their convenience at the WIH obstetric care clinic.
Primary Outcome Measure
Tdap vaccination rate for non-birthing partners [ Time Frame: During pregnancy though 1 week postpartum ]
Central Contacts
- Laurie Griffin, MD/PhD9785182135
- Adam Lewkowitz, MD/MPHS401-274-1122
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Women and Infants Hospital | Providence | Rhode Island | 02920 |